|
1
|
Zhai L, Tian X, Wang C, Cui Q, Li W, Huang SH, Yu ZX, Hong R. Construction of Morphan Derivatives by Nitroso-Ene Cyclization: Mechanistic Insight and Total Synthesis of (±)-Kopsone. Angew Chem Int Ed Engl 2017; 56:11599-11603. [DOI: 10.1002/anie.201706018] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/13/2017] [Indexed: 12/26/2022]
Affiliation(s)
- Li Zhai
- Key Laboratory of Synthetic Chemistry of Natural Substances; Shanghai Institute of Organic Chemistry (CAS); 345 Lingling Road Shanghai 200032 China
- University of the Chinese Academy of Sciences; 19A Yuquan Road Beijing 100049 China
| | - Xuechao Tian
- School of Chemical and Environmental Engineering; Shanghai Institute of Technology; 100 Haiquan Road Shanghai 201418 China
| | - Chao Wang
- Key Laboratory of Synthetic Chemistry of Natural Substances; Shanghai Institute of Organic Chemistry (CAS); 345 Lingling Road Shanghai 200032 China
- University of the Chinese Academy of Sciences; 19A Yuquan Road Beijing 100049 China
| | - Qi Cui
- College of Chemistry; Peking University; Beijing 100871 China
| | - Wenhua Li
- Key Laboratory of Synthetic Chemistry of Natural Substances; Shanghai Institute of Organic Chemistry (CAS); 345 Lingling Road Shanghai 200032 China
- University of the Chinese Academy of Sciences; 19A Yuquan Road Beijing 100049 China
| | - Sha-Hua Huang
- School of Chemical and Environmental Engineering; Shanghai Institute of Technology; 100 Haiquan Road Shanghai 201418 China
| | - Zhi-Xiang Yu
- College of Chemistry; Peking University; Beijing 100871 China
| | - Ran Hong
- Key Laboratory of Synthetic Chemistry of Natural Substances; Shanghai Institute of Organic Chemistry (CAS); 345 Lingling Road Shanghai 200032 China
- University of the Chinese Academy of Sciences; 19A Yuquan Road Beijing 100049 China
| |
Collapse
|
|
2
|
Construction of Morphan Derivatives by Nitroso-Ene Cyclization: Mechanistic Insight and Total Synthesis of (±)-Kopsone. Angew Chem Int Ed Engl 2017. [DOI: 10.1002/ange.201706018] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
|
|
3
|
Tang S, Xiong DC, Jiang S, Ye XS. Nitro-polyols via Pyridine Promoted C═C Cleavage of 2-Nitroglycals. Application to the Synthesis of (−)-Hyacinthacine A1. Org Lett 2016; 18:568-71. [DOI: 10.1021/acs.orglett.5b03607] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
Affiliation(s)
- Shengbiao Tang
- School
of Pharmaceutical Science and Technology, Tianjin University, Tianjin, 300072, China
- State
Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical
Sciences, Peking University, Xue Yuan Road No. 38, Beijing, 100191, China
| | - De-Cai Xiong
- State
Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical
Sciences, Peking University, Xue Yuan Road No. 38, Beijing, 100191, China
| | - Shende Jiang
- School
of Pharmaceutical Science and Technology, Tianjin University, Tianjin, 300072, China
| | - Xin-Shan Ye
- State
Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical
Sciences, Peking University, Xue Yuan Road No. 38, Beijing, 100191, China
| |
Collapse
|
|
4
|
Manohar M, Banister SD, Beinat C, O'Brien-Brown J, Kassiou M. Recent Advances in the Development of Sigma-1 Receptor Ligands. Aust J Chem 2015. [DOI: 10.1071/ch14590] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
The existence of two distinct sigma (σ) receptor subtypes was established in the early 1990s. Sigma-1 and sigma-2 receptors (S1Rs and S2Rs, respectively) were shown to possess distinct molecular size, anatomical distribution, and ligand discrimination. S2R is overexpressed in numerous human cancers, and has therapeutic potential for the imaging and treatment of certain tumours. In contrast, S1R is more broadly involved in a wide variety of central nervous system (CNS) diseases including motor disorders, memory deficits, depression, schizophrenia, anxiety, pain, drug addiction, and many more. Since the human S1R was cloned in 1996, numerous high affinity ligands with excellent selectivity for S1R have been developed. This review focuses on recent developments in the generation of structurally diverse S1R-selective ligands and novel therapeutic candidates targeting S1Rs.
Collapse
|